4 hours Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives Consensus Recommendation of “Buy” from Analysts MarketBeat
Shares of Aquestive Therapeutics, Inc. (NASDAQ:AQST – Get Free Report) have been assigned an average rating of “Buy” from the seven research firms that are currently covering the stock, Marketbeat reports. Six analysts have rated the stock with a buy …